fbpx
Skip to content
Force Pharma Capital
Force Pharma Capital
Life Science Consulting, Business Development and Recruiting/Staffing
  • Home
  • About Us
  • Services
  • Pharmaceutical Blog
    • RLD
    • Excipients
    • Equipment
    • Health Technology
    • Regulatory Fees
  • Contact Us
  • FAQ
  • Portfolio

Month: December 2019

FDA In Brief: New analysis highlights link between generic drug competition and lower drug prices, underscores importance of FDA efforts to spur generic drug development and market entry

December 13, 2019 Blogger Leave a comment

FDA In Brief: New analysis highlights link between generic drug competition and lower drug prices, underscores importance of FDA efforts…

Continue Reading →

Posted in: Health Technology Filed under: FDA, gdufa, RLD

FDA grants accelerated approval to first targeted treatment for rare Duchenne Muscular Dystrophy (DMD) mutation – Drug Information Update

Blogger Leave a comment

FDA grants accelerated approval to first targeted treatment for rare Duchenne Muscular Dystrophy (DMD) mutation – Drug Information Update —…

Continue Reading →

Posted in: Health Technology Filed under: approvals, FDA, pdufa

FDA Updates List of Off-Patent, Off-Exclusivity Drugs without an Approved Generic

Blogger Leave a comment

FDA Updates List of Off-Patent, Off-Exclusivity Drugs without an Approved Generic — Read on s2027422842.t.en25.com/e/es

Continue Reading →

Posted in: Uncategorized Filed under: approvals, FDA, gdufa

NIH to investigate minor cannabinoids and terpenes for potential pain-relieving properties | NCCIH

December 11, 2019 Blogger Leave a comment

This press release highlights new NCCIH research awards totaling approximately $3 million to investigate the potential pain-relieving properties and mechanisms…

Continue Reading →

Posted in: Health Technology Filed under: FDA

Targeting gut bacteria to treat alcoholic hepatitis | National Institutes of Health (NIH)

December 3, 2019 Blogger Leave a comment

A therapy targeting bacteria that make a specific toxin lessened alcohol-associated liver disease in a mouse study. — Read on…

Continue Reading →

Posted in: Health Technology Filed under: technology

Channel in Nerve Cell May be Key in Unlocking Parkinson Disease Therapy

Blogger Leave a comment

Researchers have identified a channel in nerve cells that may serve as a new approach to targeting Parkinson disease. —…

Continue Reading →

Posted in: Health Technology Filed under: fixed dose combination, technology

Drug Trials Snapshots BRUKINSA | FDA

December 1, 2019 Blogger Leave a comment

Drug Trials Snapshots — Read on www.fda.gov/drugs/resources-information-approved-drugs/drug-trials-snapshots-brukinsa More inhibitors for oncology.

Continue Reading →

Posted in: Health Technology Filed under: approvals, FDA, pdufa

Recent Posts

  • Most Recent Changes to the IID Database | FDA
  • The History, Benefits of Pharmaceutical REMS Programs
  • FDA approves first drug for treatment of peanut allergy for children

Recent Comments

  • flower bouquet delivery online on FDA Grants Priority Review to Zanubrutinib for Relapsed/Refractory Mantle Cell Lymphoma
  • cheap flowers online same day delivery on Trending News Today: Investigational Long-Acting HIV Injection Shows Efficacy in Study
  • flower arrangements for baby shower girl on FDA Grants Priority Review to Zanubrutinib for Relapsed/Refractory Mantle Cell Lymphoma

Archives

  • August 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • November 2018

Follow Us

Contact Us

  • Email
    forcepharma@icloud.com
  • Phone
    732-702-1824
  • Address
    265 Route 34 Lower Level, Colts Neck, New Jersey, 07722
Copyright © 2018 Force Pharma Capital